Klein Law Firm Announces July 20, 2021 Lead Plaintiff deadline in class action lawsuit filed on behalf of Provention Bio, Inc. Limited shareholders

New York, New York – (Newsfile Corp. – June 23, 2021) – Klein law firm announces that a class action lawsuit has been filed on behalf of shareholders of Provention Bio, Inc. (NASDAQ: PRVB) alleging that the company violated federal securities laws.

Class period: November 2, 2020 and April 8, 2021
Lead Applicant Deadline: July 20, 2021
No obligation or cost to you.

Learn more about your recoverable losses in PRVB:

Provention Bio, Inc. NEWS – PRVB NEWS

CLASS ACTION CASE DETAILS: The complaint filed alleges that Provention Bio, Inc. made materially false and / or misleading statements and / or failed to disclose that: (i) the teplizumab (“BLA”) biologics license application was deficient in its submitted form and would require additional data to obtain US Food and Drug Administration approval; (ii) as a result, teplizumab BLA lacked evidence that the Company had led investors to believe it possessed; (iii) the Company had thus overestimated the prospects for approval of teplizumab BLA and therefore the schedule for marketing teplizumab; and (iv) accordingly, the Company’s public statements were materially false and misleading at all material times.

WHAT THIS MEANS FOR YOU AS A SHAREHOLDER: If you have suffered a loss in Provention Bio, you have up to July 20, 2021 apply to the court for principal applicant status. Your ability to participate in any recovery does not require you to serve as the principal applicant.

NO COT FOR YOU: If you purchased Provention Bio securities during the relevant period, you may be entitled to compensation without payment of reimbursable costs.

HOW TO PROTECT YOUR FINANCIAL INTERESTS: For more information on the PRVB trial, please contact J. Klein, Esq. by phone at 212-616-4899 or click on this link.

J. Klein, Esq. represents investors and participates in securities litigation involving financial fraud nationwide. Klein Law Firm is a litigation firm with experience in a wide range of areas including securities law, corporate finance and commercial litigation. Since 2011, our experienced lawyers have achieved superior results for our clients with a personalized approach. Lawyer advertising. Past results do not guarantee similar results.

J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th floor
New York, New York 10118
[email protected]
Telephone: (212) 616-4899
Fax: (347) 558-9665

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/88492

About the author